Clicky

Sysmex Corp ADR(SSMXY)

Description: Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, sale, and export/import of diagnostic instruments, reagents, and related software for the use in hematology, urinalysis, immunochemistry, clinical chemistry, and hemostasis. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; systems for high-volume testing in labs; and hematology analyzers for animals. The company also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for to test for liver fibrosis progression and atopic dermatitis; and support services for hemostasis products. In addition, it offers systems for the detection of cancer lymph node metastasis; cytogenic testing services; and lab assay services. It serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. The company operates in the Americas, Europe, the Middle East, Africa, the Asia Pacific, China, and Japan. Sysmex Corporation has collaboration with MolecularMD Corporation to develop and commercialize companion diagnostics. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.


Keywords: Hematology Blood Atopic Dermatitis Dermatitis Fibrosis Urine Companion Liver Fibrosis Research Institute Hemostasis Metastasis Blood Cell Kobe Academic Journals Analysis Systems Hematology Analyzer Hemostasis Products Hematology Analyzers Cancer Lymph Node Metastasis Cytogenic Testing Services Immunochemistry Systems Lab Assay Services Sediment Analysis Systems Sysmex Corporation

Home Page: www.sysmex.co.jp

1-5-1 Wakinohama-kaigandori
Kobe, 651-0073
Japan
Phone: 81 78 265 0500


Officers

Name Title
Mr. Hisashi Ietsugu Chairman of the Managing Board & CEO
Mr. Kaoru Asano CTO, Sr. MD, Sr. Exec. Officer, Sr. MD & Member of the Managing Board
Mr. Iwane Matsui MD of Global Marketing, Sr. Exec. Officer & Member of Managing Board
Mr. Kenji Tachibana Sr. MD of Corp Mgmt & Regulatory Affairs, Sr. Exec. Officer & Member of the Managing Board
Mr. Hiroshi Kanda MD of Bus. Strategy Devel., Sr. Exec. Officer & Member of the Managing Board
Mr. Mamoru Kubota Sr. Exec. Officer & Deputy in charge of Bus. Strategy Devel.
Mr. Kensuke Lizuka Sr. Exec. Officer & Exec. VP of Corp. Bus. Planning Div.
Mr. Tomokazu Yoshida Sr. Exec. Officer, MD of R&D, Incubation & MR Bus. and Member of the Managing Board
Mr. Takashi Ono Sr. Exec. Officer
Mr. Mitsuhisa Kanagawa Exec. Officer of IVD Bus. Unit & Exec. VP of Bus. Strategy Devel.

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 30.3951
Trailing PE: 37.8916
Price-to-Book MRQ: 4.9358
Price-to-Sales TTM: 0.0344
IPO Date:
Fiscal Year End: March
Full Time Employees: 8771
Back to stocks